We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Instem Plc | LSE:INS | London | Ordinary Share | GB00B3TQCK30 | ORD 10P |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
- |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
- | O | 0 | 830.00 | GBX |
Date | Time | Source | Headline |
---|---|---|---|
21/11/2023 | 07:00 | UKREG | AIM Cancellation - Instem Plc |
21/11/2023 | 07:00 | UKREG | Instem plc Cancellation of admission to trading |
20/11/2023 | 12:33 | UKREG | Instem plc Scheme becomes Effective |
20/11/2023 | 07:30 | UKREG | AIM Suspension - Instem PLC |
17/11/2023 | 12:00 | UKREG | Stifel Nicolaus Europe Limited Form 8.5 (EPT/RI) - Instem plc |
16/11/2023 | 19:30 | ALNC | TRADING UPDATES: Instem acquisition by Ichor sanctioned by UK court |
16/11/2023 | 15:23 | UKREG | Instem plc Issuance of Shares following Court Sanction |
16/11/2023 | 14:30 | UKREG | Instem plc Court Sanction of the Scheme |
16/11/2023 | 10:02 | UKREG | Singer Capital Markets Sec Ltd Form 8.5 (EPT/RI) |
15/11/2023 | 13:40 | UKREG | Samson Rock Capital LLP Form 8.3 - Instem Plc |
Instem (INS) Share Charts1 Year Instem Chart |
|
1 Month Instem Chart |
Intraday Instem Chart |
Date | Time | Title | Posts |
---|---|---|---|
30/12/2023 | 14:44 | Aviva deserve to pay BIG PRICE. BOYCOTT | 2 |
02/11/2023 | 18:26 | Instem Life | 273 |
26/11/2019 | 16:54 | chevy retail 250 | 1 |
02/1/2012 | 22:19 | INSULTS...what is the best one ? | 11 |
05/1/2010 | 16:26 | Newbie to BB ! any viewpoint | 30 |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|
Top Posts |
---|
Posted at 20/10/2023 09:23 by 1c3479z looks as though the t/o is edging towards the required majority, generally a rather lukewarm reception: on the other hand, no alternative on offer, suspect the share price would fall back into the 500s if it doesn't go through? Market quite unforgiving presently.Had cvsg/ergo down as alternatives until the CMA started its investigations and other developments. |
Posted at 13/10/2023 12:39 by p1nkfish The close price at the end of today will be interesting as well as the Monday open. A chance there will be signals to interpret in both. The clever ones took money off the table when the offer landed.Used to own Instem from sub £3 and exited too early about £7.50. Not so sure this time. Hope you all make a decent return and it goes from strength to strength under any new owner. |
Posted at 13/10/2023 12:36 by p1nkfish Agreed tt but too many unknowns and the only things I can know is where my stop would sit and the potential risk vs reward.Lion will also pay a price if they allow this to be sold at what they think is too cheap. Future Lion investors will be more sceptical of Lions assessment of a company future value potential. |
Posted at 13/10/2023 12:18 by tradertrev Liontrust need performance in their funds. They really don't need a big position like this to fall back sharply. Take a look at Liontrust's share price! |
Posted at 13/10/2023 11:22 by p1nkfish The Cannacord Genuity sales and Lion not being happy and the confirmation of no higher offer from the bidder - does suggest its close to the wire and if voted down there will be a fall back. It needs another bidder to join the party.I think the price softness does suggest there is increasing risk it will be voted down with no plan B except to continue as it was prior to the bid. If it does get voted down where do people think the price can fall to? Updside is defined. Timescales to clarify. Downside definition? What probability, falls to what price. Could happy quickly and near-term. Very tempting but not guaranteed upside and a pretty big downside potential and can't guess the probability of up vs down. |
Posted at 13/10/2023 10:13 by ahhh luke warm When is this deal set to close Trev? Seems like a good opportunity to accumulate if the price is 765 or below. Not dug into the terms yet, just noticed the RNS today. Cheers :-) |
Posted at 30/8/2023 10:42 by tradertrev Carefully judged bid price, but at/below where they were trading 18-24 months ago (and where I took some profit). Shows how the UK small-cap malaise is undervaluing stocks. It usually takes corporate M&A to demonstrate this value on offer. The penny will drop eventually and we should start to see some money flows into small-cap.I did often wonder how much longer the CEO would want to keep running this show. As regards competing offers, it's interesting to note that there are very few business synergies with the acquiror, so a decent sized competitor may well be interested in getting involved, as potentially more value on offer in such a tie-up. |
Posted at 30/8/2023 08:52 by mammyoko Market price suggesting a competing bid may emerge? |
Posted at 30/8/2023 07:13 by w t tutte Not a shareholder but if I were I would be pretty disappointed that they have not run a formal sale process. This is a quality business that appears to be being sold by management too cheaply and without any external competition.I am pretty confident there would be a number of interested parties and it would have resulted in a meaningfully higher takeout price. I am going to put these board members on my do not operate in the best interest of shareholders list. |
Posted at 15/8/2023 14:46 by km18 Instem plc issued a solid trading update for H1 2023 indicating that revenue is expected to be around £29.7m, an increase of approximately 10.2%. The Group's balance sheet remains strong, closing cash at 30 June 2023 was £8.4m. With an increasing number of customer touch points and cross selling opportunities management is confident that Instem's performance will be broadly in line with the Board's expectations for the full year. Consensus expectations are for revenues of £65.5m and statutory net profit of £7.2m, growth of 11% and 53% respectively. Valuation is average with forward PE ratio of 18.8x and PS ratio at 2.4x both mid third for the Software & IT Services sector. The share price is in a longer run consolidation phase and lacks momentum for the time being. INS is a solid growth niche Software name at a decent price, but it is a share to monitor for the time being......from WealthOracle |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions